{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:27:30Z","timestamp":1788532050366,"version":"build-2803163510"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,15]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Type 2 diabetes mellitus (T2DM) has been linked to several types of cancer, including breast cancer. Glycated hemoglobin (HbA1c) serves as an indicator of long-term blood sugar control, and elevated levels may contribute to the development of breast cancer. This study aims to evaluate the association between elevated HbA1c levels and breast cancer risk in women with T2DM attending a tertiary care hospital in South India, and to compare HbA1c levels between diabetic women with and without breast cancer. A retrospective case-control study was conducted at Kovai Medical Center from 2014 to 2016 among women with T2DM. Breast cancer was histopathologically confirmed. Data on HbA1c (&lt;7.0% vs \u22657.0%), body mass index, diabetes duration, menopausal status, and family history were collected. Associations with breast cancer risk were analyzed using Chi-square tests and logistic regression adjusted for confounders, with significance set at\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05. The study included 182 women with T2DM and breast cancer and 197 age-matched controls without breast cancer. Poor glycemic control (HbA1c\u2005\u2265\u20057.0%) was more prevalent among cases and significantly associated with breast cancer in multivariable logistic regression adjusting for age, body mass index, menopausal status, diabetes duration, and insulin use (adjusted OR\u2005=\u20052.98, 95% CI: 1.08\u20138.21,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.0001). Additional risk factors included postmenopausal status (OR\u2005=\u20054.52, 95% CI: 1.36\u201315.00), age 50 to 59 years (OR\u2005=\u20058.30, 95% CI: 2.80\u201319.32), and insulin use (OR\u2005=\u20052.57, 95% CI: 1.04\u20133.21). Most cases were estrogen receptor and progesterone receptor negative, with 63% diagnosed at stage I. Advanced stages (II\/III), triple-negative breast cancer (OR\u2005=\u20052.78, 95% CI: 1.05\u20133.65), and higher Ki-67 index (intermediate: OR\u2005=\u20051.91, high: OR\u2005=\u20053.00) were linked to more aggressive disease. In this retrospective case-control study, higher HbA1c levels (\u22657.0%) were associated with breast cancer presence and more advanced tumor stages among women with T2DM, although the odds ratio for HbA1c should be interpreted cautiously. Postmenopausal status and insulin use were more common among cases, while metformin use showed a nonsignificant inverse trend. triple-negative breast cancer status and higher Ki-67 index were also more frequent in advanced disease.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048787","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:02:29Z","timestamp":1778896949000},"page":"e48787","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association between HbA1c and breast cancer risk in women with type 2 diabetes mellitus: A case-control study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1552-7978","authenticated-orcid":false,"given":"Geetha","family":"Kandasamy","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9924-7924","authenticated-orcid":false,"given":"Vijayakumar","family":"Arumugam","sequence":"additional","affiliation":[{"name":"Head Pharmacy Services, Kovai Medical Center and Hospital, Coimbatore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Orayj","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahani","family":"S. Alanazi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayah","family":"Asiri","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma M.","family":"Alshahrani","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, Shaqra University, Dawadimi, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amjad","family":"Hmlan","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majed","family":"Sulaiman A Abumelha","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Armed Forces Hospital Southern Region, Ministry of Defense Health Services, Khamis Mushait, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Abudulaziz Mohammed","family":"Turki","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Armed Forces Hospital Southern Region, Ministry of Defense Health Services, Khamis Mushait, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanitha Innocent","family":"Rani","sequence":"additional","affiliation":[{"name":"Department of Community and Psychiatric Nursing, Faculty of Nursing, King Khalid University, Muhayil, Asir Region, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geethu Grace","family":"Prakash","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, KMCH College of Pharmacy, Coimbatore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8440-8366","authenticated-orcid":false,"given":"Vasudevan","family":"Mani","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karema","family":"Abu-Elfotuh","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt"},{"name":"College of Pharmacy, Al-Ayen Iraqi University, AUIQ, An Nasiriyah, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousalya","family":"Prabahar","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260904","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R5-20260904","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.3390\/ijms21176275","article-title":"Pathophysiology of type 2 diabetes mellitus.","volume":"21","author":"Galicia-Garcia","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R6-20260904","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2337\/diaspect.27.4.276","article-title":"The diabetes-cancer link.","volume":"27","author":"Collins","year":"2014","journal-title":"Diabetes Spectr"},{"key":"R7-20260904","doi-asserted-by":"crossref","first-page":"g7607","DOI":"10.1136\/bmj.g7607","article-title":"Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies.","volume":"350","author":"Tsilidis","year":"2015","journal-title":"BMJ"},{"key":"R8-20260904","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death.","volume":"364","author":"Seshasai","year":"2011","journal-title":"N Engl J Med"},{"key":"R9-20260904","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.3390\/ijms25137476","article-title":"Associations between diabetes mellitus and selected cancers.","volume":"25","author":"Pliszka","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R10-20260904","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2337\/dc12-0002","article-title":"Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults.","volume":"35","author":"Campbell","year":"2012","journal-title":"Diabetes Care"},{"key":"R11-20260904","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1007\/s00125-017-4229-z","article-title":"Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium.","volume":"60","author":"Chen","year":"2017","journal-title":"Diabetologia"},{"key":"R12-20260904","doi-asserted-by":"crossref","first-page":"FSO248","DOI":"10.4155\/fsoa-2017-0081","article-title":"Patient outcomes from lung cancer and diabetes mellitus: a matched case-control study.","volume":"4","author":"Karlin","year":"2018","journal-title":"Future Sci OA"},{"key":"R13-20260904","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/cd19-0077","article-title":"Review of associations between type 2 diabetes and cancer.","volume":"38","author":"Bonagiri","year":"2020","journal-title":"Clin Diabetes"},{"key":"R14-20260904","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s13105-025-01084-9","article-title":"Mechanisms underlying obesity-malignancy connection: a systematic narrative review.","volume":"81","author":"Sultana","year":"2025","journal-title":"J Physiol Biochem"},{"key":"R15-20260904","doi-asserted-by":"crossref","first-page":"1396022","DOI":"10.3389\/fendo.2024.1396022","article-title":"Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms.","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R16-20260904","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.bbrc.2017.11.182","article-title":"Advanced glycation end products promote triple negative breast cancer cells via ERK and NF-\u03baB pathway.","volume":"495","author":"Lee","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"R17-20260904","doi-asserted-by":"crossref","first-page":"e002697","DOI":"10.1136\/bmjdrc-2021-002697","article-title":"Advanced glycation end products correlate with breast cancer metastasis by activating RAGE\/TLR4 signaling.","volume":"10","author":"Pan","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"key":"R18-20260904","doi-asserted-by":"crossref","first-page":"e199139","DOI":"10.1001\/jamanetworkopen.2019.9139","article-title":"Association between clinical practice group adherence to quality measures and adverse outcomes among adult patients with diabetes.","volume":"2","author":"Gilstrap","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R19-20260904","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1038\/bjc.2014.150","article-title":"Does cancer risk increase with HbA1c, independent of diabetes?","volume":"110","author":"De Beer","year":"2014","journal-title":"Br J Cancer"},{"key":"R20-20260904","doi-asserted-by":"crossref","first-page":"183928","DOI":"10.1155\/2015\/183928","article-title":"Type 2 diabetes and breast cancer: the interplay between impaired glucose metabolism and oxidant stress.","volume":"2015","author":"Ferroni","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"R21-20260904","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4093\/dmj.2020.0250","article-title":"Hyperinsulinemia in obesity, inflammation, and cancer.","volume":"45","author":"Zhang","year":"2021","journal-title":"Diabetes Metab J"},{"key":"R22-20260904","doi-asserted-by":"crossref","first-page":"789174","DOI":"10.1155\/2012\/789174","article-title":"Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms.","volume":"2012","author":"Arcidiacono","year":"2012","journal-title":"Exp Diabetes Res"},{"key":"R23-20260904","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.4103\/ijo.IJO_1627_21","article-title":"Epidemiology of type 2 diabetes in India.","volume":"69","author":"Pradeepa","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R24-20260904","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbacli.2016.04.005","article-title":"Relationship between level of HbA1C and breast cancer.","volume":"6","author":"Fariba","year":"2016","journal-title":"BBA Clin"},{"key":"R25-20260904","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.3390\/cancers16162853","article-title":"Impact of breast cancer on cardiometabolic health in Spanish women \u226550 years with pre-existing type 2 diabetes mellitus.","volume":"16","author":"Fern\u00e1ndez-Arce","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"Suppl 1","key":"R28-20260904","first-page":"S1","article-title":"Standards of care in diabetes\u20142023.","volume":"46","year":"2023","journal-title":"Diabetes Care"},{"key":"R30-20260904","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/epirev\/mxt010","article-title":"Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status.","volume":"36","author":"Munsell","year":"2014","journal-title":"Epidemiol Rev"},{"key":"R31-20260904","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10549-014-3146-9","article-title":"Diabetes, diabetes treatment and breast cancer prognosis.","volume":"148","author":"Luo","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"R32-20260904","first-page":"271","article-title":"Type 2 diabetes and all-cause mortality among Spanish women with breast cancer.","volume":"33","author":"Fern\u00e1ndez-Arce","year":"2022","journal-title":"Cancer Causes Control"},{"key":"R33-20260904","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/eurpub\/ckw070","article-title":"Socioeconomic inequalities in breast cancer incidence and mortality in Europe-a systematic review and meta-analysis.","volume":"26","author":"Lundqvist","year":"2016","journal-title":"Eur J Public Health"},{"key":"R34-20260904","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1021\/acsptsci.4c00684","article-title":"Glycation of proteins and its end products: from initiation to natural product-based therapeutic preventions.","volume":"8","author":"Burman","year":"2025","journal-title":"ACS Pharmacol Transl Sci"},{"key":"R35-20260904","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.bbadis.2014.12.009","article-title":"Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231.","volume":"1852","author":"Sharaf","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"R36-20260904","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1186\/s12885-015-1876-7","article-title":"Prolonged use of human insulin increases breast cancer risk in Taiwanese women with type 2 diabetes.","volume":"15","author":"Tseng","year":"2015","journal-title":"BMC Cancer"},{"key":"R37-20260904","doi-asserted-by":"crossref","first-page":"11137","DOI":"10.3390\/ijms222011137","article-title":"Insulin resistance and cancer: in search for a causal link.","volume":"22","author":"Chiefari","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R38-20260904","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.annonc.2020.12.008","article-title":"A prospective study of type 2 diabetes, metformin use, and risk of breast cancer.","volume":"32","author":"Park","year":"2021","journal-title":"Ann Oncol"},{"key":"R39-20260904","first-page":"281","article-title":"Expressions of IGF-1R and Ki-67 in breast cancer patients with diabetes mellitus and an analysis of biological characteristics.","volume":"38","author":"Yan","year":"2022","journal-title":"Pak J Med Sci"},{"key":"R40-20260904","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1200\/JCO.2009.27.3011","article-title":"Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis.","volume":"29","author":"Peairs","year":"2011","journal-title":"J Clin Oncol"},{"key":"R41-20260904","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1200\/JCO.2010.29.3183","article-title":"Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer.","volume":"29","author":"Erickson","year":"2011","journal-title":"J Clin Oncol"},{"key":"R42-20260904","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1007\/s40618-024-02417-z","article-title":"Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view.","volume":"47","author":"Natalicchio","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"R43-20260904","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.3390\/jcm11195933","article-title":"Association of glycosylated hemoglobin level and cancer-related mortality in patients without diabetes.","volume":"11","author":"Yoo","year":"2022","journal-title":"J Clin Med"},{"key":"R44-20260904","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2337\/dc10-2010","article-title":"Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiography.","volume":"34","author":"Silbernagel","year":"2011","journal-title":"Diabetes Care"},{"key":"R45-20260904","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1210\/clinem\/dgaf285","article-title":"Biomarkers of insulin resistance and their performance as predictors of treatment response in overweight adults.","volume":"111","author":"Brogan","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"R46-20260904","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","article-title":"Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis.","volume":"363","author":"Renehan","year":"2004","journal-title":"Lancet"},{"key":"R47-20260904","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/10408363.2011.599831","article-title":"Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer.","volume":"48","author":"Allin","year":"2011","journal-title":"Crit Rev Clin Lab Sci"},{"key":"R48-20260904","first-page":"1061","article-title":"Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature.","volume":"12","author":"Liao","year":"2011","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:02:18Z","timestamp":1788530538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":42,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048787","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"2025-11-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}